tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Steven Breazzano, 4 are a HOLD (44.44%), 5 are a BUY (55.56%).
Analyst Steven Breazzano, currently employed carries an average stock price target met ratio of 100% that have a potential upside of 21.91% achieved within 179 days. Previously, Steven Breazzano worked at PIPER SANDLER.
Steven Breazzano’s has documented 19 price targets and ratings displayed on 2 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on RARE, Ultragenyx at 23-Mar-2017.
Analyst best performing recommendations are on RARE (ULTRAGENYX).
The best stock recommendation documented was for RARE (ULTRAGENYX) at 11/1/2016. The price target of $82 was fulfilled within 10 days with a profit of $21.78 (36.17%) receiving and performance score of 36.17.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
2 years 6 months 7 days ago
(14-Jun-2022)
0/10 (0%)
$4.56 (102.70%)
Hold
$4.75
$4.66 (5177.78%)
$5.75
3 years 1 months 18 days ago
(03-Nov-2021)
10/12 (83.33%)
$0.06 (1.28%)
65
Sell
4 years 1 months 15 days ago
(06-Nov-2020)
3/5 (60%)
$5.73 (134.19%)
42
Buy
$16
$15.91 (17677.78%)
$17
4 years 4 months 14 days ago
(07-Aug-2020)
5/12 (41.67%)
$10.58 (195.20%)
77
Sell
$4
$3.91 (4344.44%)
$3
4 years 7 months 15 days ago
(06-May-2020)
3/5 (60%)
$-4.07 (-50.43%)
191
What Year was the first public recommendation made by Steven Breazzano?
